There are only three ways for a patient to ethically access a medicine: through clinical trials, unlicensed or licensed supply. 

Our unique business model allows us to manage access to all three routes worldwide. We add insight, expertise and value at every stage of the product life cycle.

Click the business model below to enlarge: